Framingham Risk Score with Cardiovascular Events in Chronic Kidney Disease

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Chen, Szu Chia ^a,b,c   Su, Ho Ming ^a,b,c   Tsai, Yi Chun ^a   Huang, Jiun Chi ^a,b   Chang, Jer Ming ^a,b,c   Hwang, Shang Jyh ^a,c   Chen, Hung Chun ^a,c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HEMOGLOBIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FRAMINGHAM RISK SCORE; GLOMERULUS FILTRATION RATE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PREDICTIVE VALUE; PROTEINURIA; RISK ASSESSMENT; TAIWAN;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RESEARCH DESIGN; RISK ASSESSMENT; TAIWAN;

EID: 84875178460     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060008     Document Type: Article

References (36)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305.
2. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, et al. (2006) Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 17: 2034-2047.
3. Olivero JJ, Nguyen P, (2009) Chronic kidney disease: A marker of cardiovascular disease. Methodist Debakey Cardiovasc J 5: 24-29.
4. Rodriguez-Iturbe B, Correa-Rotter R, (2010) Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease. Expert Opin Pharmacother 11: 2687-2698.
5. Zoccali C, Benedetto FA, Tripepi G, Mallamaci F, Rapisarda F, et al. (2006) Left ventricular systolic function monitoring in asymptomatic dialysis patients: A prospective cohort study. J Am Soc Nephrol 17: 1460-1465.
6. Silberberg JS, Barre PE, Prichard SS, Sniderman AD, (1989) Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36: 286-290.
7. Cintron G, Johnson G, Francis G, Cobb F, Cohn JN, (1993) Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The v-heft va cooperative studies group. Circulation 87: VI17-23.
8. Third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) final report. Circulation 106: 3143-3421.
9. Sarnak MJ, Levey AS, (2003) Schoolwerth AC, Coresh J, Culleton B, et al (2003) Kidney disease as a risk factor for development of cardiovascular disease: A statement from the american heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension 42: 1050-1065.
10. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD, (2003) Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63: 793-808.
11. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, et al. (2007) The framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol 50: 217-224.
12. Wannamethee SG, Shaper AG, Lennon L, Morris RW, (2005) Metabolic syndrome vs framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165: 2644-2650.
13. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, et al. (2006) Arterial stiffness and risk of coronary heart disease and stroke: The rotterdam study. Circulation 113: 657-663.
14. Mitchell GF, (2004) Increased aortic stiffness: An unfavorable cardiorenal connection. Hypertension 43: 151-153.
15. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, et al. (2008) Ankle brachial index combined with framingham risk score to predict cardiovascular events and mortality: A meta-analysis. JAMA 300: 197-208.
16. Kavousi M, Elias-Smale S, Rutten JH, Leening MJ, Vliegenthart R, et al. (2012) Evaluation of newer risk markers for coronary heart disease risk classification: A cohort study. Ann Intern Med 156: 438-444.
17. Chen SC, Chang JM, Liu WC, Huang JC, Tsai JC, et al. (2012) Echocardiographic parameters are independently associated with increased cardiovascular events in patients with chronic kidney disease. Nephrol Dial Transplant 27: 1064-1070.
18. Liu WC, Hung CC, Chen SC, Yeh SM, Lin MY, et al. (2012) Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality. Clin J Am Soc Nephrol 7: 541-548.
19. Levey AS, Coresh J, Bolton K, Culleton B, Harvey KS, et al. (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-266.
20. Helmcke F, Nanda NC, Hsiung MC, Soto B, Adey CK, et al. (1987) Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 75: 175-183.
21. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 57: 450-458.
22. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, et al. (2007) 2007 guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the european society of hypertension (esh) and of the european society of cardiology (esc). J Hypertens 25: 1105-1187.
23. Vickery S, Stevens PE, Dalton RN, van Lente F, Lamb EJ, (2006) Does the id-ms traceable mdrd equation work and is it suitable for use with compensated jaffe and enzymatic creatinine assays? Nephrol Dial Transplant 21: 2439-2445.
24. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130: 461-470.
25. Uno H, Cai T, Pencina MJ, D'Agostino RB, Wei LJ, (2011) On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Statistics in Medicine 30: 1105-1117.
26. Chen SC, Chang JM, Hwang SJ, Tsai JC, Liu WC, et al. (2010) Ankle brachial index as a predictor for mortality in patients with chronic kidney disease and undergoing haemodialysis. Nephrology (Carlton) 15: 294-299.
27. Knight EL, Rimm EB, Pai JK, Rexrode KM, Cannuscio CC, et al. (2004) Kidney dysfunction, inflammation, and coronary events: A prospective study. J Am Soc Nephrol 15: 1897-1903.
28. Hallan S, Astor B, Romundstad S, Aasarod K, Kvenild K, et al. (2007) Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The hunt ii study. Arch Intern Med 167: 2490-2496.
29. Zethelius B, Berglund L, Sundstrom J, Ingelsson E, Basu S, et al. (2008) Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358: 2107-2116.
30. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, et al. (2011) The definition, classification, and prognosis of chronic kidney disease: A kdigo controversies conference report. Kidney Int 80: 17-28.
31. Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G, (2005) Left ventricular hypertrophy in nondiabetic predialysis ckd. Am J Kidney Dis 46: 320-327.
32. Stewart GA, Gansevoort RT, Mark PB, Rooney E, McDonagh TA, et al. (2005) Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int 67:2 117-226.
33. Eckardt KU, Scherhag A, Macdougall IC, Tsakiris D, Clyne N, et al. (2009) Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in ckd. J Am Soc Nephrol 20: 2651-2660.
34. Kim SJ, Han SH, Park JT, Kim JK, Oh HJ, et al. (2011) Left atrial volume is an independent predictor of mortality in capd patients. Nephrol Dial Transplant 26: 3732-3739.
35. Ristow B, Ali S, Whooley MA, Schiller NB, (2008) Usefulness of left atrial volume index to predict heart failure hospitalization and mortality in ambulatory patients with coronary heart disease and comparison to left ventricular ejection fraction (from the heart and soul study). Am J Cardiol 102: 70-76.
36. Silaruks S, Sirivongs D, Chunlertrith D, (2000) Left ventricular hypertrophy and clinical outcome in capd patients. Perit Dial Int 20: 461-466.